Intravitreal Injectable Market size was valued at USD 3.21 Billion in 2024 and is projected to reach USD 5.82 Billion by 2033, exhibiting a CAGR of 7.4% from 2026 to 2033.
The Intravitreal Injectable Market in South Korea is experiencing significant growth, driven by increasing prevalence of retinal disorders and advancements in ophthalmic treatments. In 2023, the market revenue reached USD 150.7 million and is projected to grow at a CAGR of 11.4% to USD 320.9 million by 2030.
Key Market Segments:
Macular Degeneration: The largest revenue-generating segment in 2023.
Diabetic Retinopathy: Expected to be the fastest-growing segment during the forecast period.
Anti-VEGF agents are the predominant treatment in the intravitreal injectable market, accounting for a significant share due to their efficacy in treating retinal disorders. The convenience and effectiveness of these agents have made them a preferred choice among ophthalmologists.
Industry Requirements and Trends:
Technological Advancements: Development of sustained-release corticosteroids like the dexamethasone intravitreal implant (DEX-implant) offers longer-lasting treatment effects, reducing the frequency of injections.
Healthcare Infrastructure: Improved diagnostic equipment and procedures enable earlier diagnosis of eye problems, increasing demand for ophthalmic injectables as a therapy option.
Regulatory Approvals: Inclusion of treatments like ranibizumab and aflibercept in the Korean National Health Insurance has facilitated wider adoption.
From my experience in the field, the integration of advanced drug delivery systems and supportive healthcare policies in South Korea has significantly contributed to the growth of the intravitreal injectable market. The focus on patient-centric care and the adoption of innovative treatments are expected to sustain this growth trajectory.
As the market continues to evolve, stakeholders must stay abreast of emerging trends and technological innovations to meet the growing demand and improve patient outcomes in the ophthalmic sector.
Get an In-Depth Research Analysis of the South Korea Intravitreal Injectable Market Size And Forecast [2025-2032]
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Intravitreal Injectable Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Intravitreal Injectable Market
Anti-VEGF Injectables
Corticosteroids
Gene Therapy Products
Other Drug Types
Age-Related Macular Degeneration (AMD)
Diabetic Macular Edema (DME)
Retinal Vein Occlusion (RVO)
Diabetic Retinopathy (DR)
Uveitis
Others
Hospitals
Ambulatory Surgical Centers (ASCs)
Ophthalmology Clinics
Research and Academic Institutions
Intravitreal Injection
Intramuscular Injection
Intradermal Injection
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Direct Procurement
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Intravitreal Injectable Market Research Analysis
1. Introduction of the South Korea Intravitreal Injectable Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Intravitreal Injectable Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Intravitreal Injectable Market, By Type
6. South Korea Intravitreal Injectable Market, By Application
7. South Korea Intravitreal Injectable Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Intravitreal Injectable Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/